Model predictive control for the prescription of antithyroid agents [PDF]
CoRR, 2023 2 ...
Maylin Menzel +3 more
openaire +3 more sources
Mechanism of the Inhibition of Enzymatic Halogenation by Antithyroid Agents
Journal of Biological Chemistry, 1966 Abstract Antithyroid agents of the thiourea type (thiourea, thiouracil, and 5-vinyl-2-oxazolidinethione) inhibit the enzymatic halogenation reactions catalyzed by chloroperoxidase. These compounds are competitive with the halogen acceptor molecule and serve as substrates for chloroperoxidase. These antithyroid agents are oxidized by chloroperoxidase in
D R, Morris, L P, Hager
openaire +3 more sources
Thyroid storm: a case of haemodynamic failure promptly reversed by aggressive medical therapy with antithyroid agents and steroid pulse. [PDF]
BMJ Case Rep, 2018 Hyperthyroidism is a common metabolic disorder, although its presentation as an endocrine emergency called thyroid storm is rare. Here we review a case of a thyroid storm as the initial presentation of thyrotoxicosis, with multiple organ failure and ...
Andrade Luz I, Pereira T, Catorze N.
europepmc +2 more sources
The potential for repositioning antithyroid agents as antiasthma drugs [PDF]
Journal of Allergy and Clinical Immunology, 2016 Shoichi Suzuki +18 more
openaire +3 more sources
A SEARCH FOR ANTITHYROID AGENTS
Journal of Biological Chemistry, 1956 N, KHARASCH, E C, STOWELL, H P, VIND
openaire +3 more sources
Antithyroid arthritis syndrome caused by methimazole in a patient with Graves’ disease
Endocrinology, Diabetes & Metabolism Case Reports, 2023 This is a report on antithyroid arthritis syndrome (AAS) which is a rare adverse effect of antithyroid agents. AAS presents with severe symptoms including myalgia, arthralgia, arthritis, fever, and skin eruption due to the use of antithyroid agents.
Muneo Kawasumi +3 more
doaj +1 more source
Characteristics of Korean Patients with Antithyroid Drug-Induced Agranulocytosis: A Multicenter Study in Korea [PDF]
Endocrinology and Metabolism, 2015 BackgroundAntithyroid drugs (ATDs) can lead to the development of agranulocytosis, which is the most serious adverse effect. Characteristics of ATD-induced agranulocytosis (AIA) have seldom been reported due to the rarity. In this study, we characterized
Hee Kyung Kim +11 more
doaj +1 more source
Remission in pediatric Graves’ disease treated with antithyroid drug and the risk factors associated with relapse [PDF]
Annals of Pediatric Endocrinology & Metabolism, 2022 Purpose To evaluate the characteristics and frequency of remission in pediatric patients with Graves’ disease (GD) treated with antithyroid drug (ATD) and to identify factors that may be associated with relapse.
Tsz Wai Catherine Wong +1 more
doaj +1 more source
The treatment of Graves' disease in children and adolescents [PDF]
Annals of Pediatric Endocrinology & Metabolism, 2014 Graves' disease (GD) accounts for 10%-15% of thyroid disorders in children and adolescents. The use of antithyroid drugs as the initial treatment option in GD is well accepted.
Hae Sang Lee, Jin Soon Hwang
doaj +1 more source
Clinical characteristics of antithyroid drug-induced aplastic anemia cases over the past 30 years
Frontiers in Endocrinology, 2023 ObjectiveThe authors aimed to investigate the clinical characteristics of antithyroid drug-induced aplastic anemia cases over the past 30 years.MethodsThe data of patients with antithyroid drug-induced aplastic anemia were retrieved from PubMed and ...
Ying Cheng +7 more
doaj +1 more source